Alibaba just pulled off the biggest follow-on share sale in Hong Kong’s history, raising HK$80 billion (roughly $10.2 billion) by issuing 710 million new ordinary shares. The price: HK$112.70 per share, offered primarily to non-US institutional investors over August 23-24.
The market’s initial reaction was about as warm as you’d expect when a company floods the market with new stock. Shares dropped 8.5% in Hong Kong trading, the steepest single-session decline the company has seen since early 2025.
But here’s what made the situation interesting: within hours of that drop, Alibaba Chairman Joseph Tsai and CEO Eddie Wu started buying. The two executives collectively picked up approximately 1.1 million shares worth around $15.3 million on August 24, essentially telling the market they believe the stock is underpriced at its post-dilution level.
The insider purchases
Tsai’s purchase was the larger of the two, totaling roughly 720,000 shares at an estimated cost of $10.3 million. Wu picked up about 350,000 shares for approximately $5 million.
In US trading, the damage was more muted. Alibaba’s American depositary shares slipped between 0.7% and 2.4%, suggesting that much of the selling pressure was concentrated in Hong Kong where the new shares were actually issued.
Where the $10 billion is going
Every dollar of net proceeds from the offering is earmarked for a single purpose: AI infrastructure and capabilities. Not debt repayment, not share buybacks, not general corporate purposes. All AI, all the time.
How severe? Alibaba’s most recent quarterly results showed net income declining by 75%. That number reflects, in large part, the massive capital expenditures the company is already pouring into AI development. The $10.2 billion raise suggests leadership believes those investments need to accelerate, not slow down.
The offering was oversubscribed nearly three times, which means institutional demand for the shares significantly exceeded supply despite the dilutive nature of the deal.
The broader context
For Chinese tech companies specifically, the stakes are amplified by geopolitical competition. US restrictions on advanced semiconductor exports have created urgency around developing domestic AI capabilities, making the race for AI infrastructure as much a national priority as a corporate one.
Alibaba’s choice to route this massive offering through Hong Kong rather than New York also reflects the evolving geography of Chinese tech capital raising. By targeting non-US institutional investors, the company sidesteps some of the regulatory complexity that comes with US-listed Chinese equities while tapping into deep pools of Asian and European institutional capital.
What to watch from here
The 75% decline in net income is the number that will hang over every quarterly earnings call until AI investments start generating measurable returns. Investors have shown willingness to fund the vision, as evidenced by the nearly three-times oversubscription, but patience with declining profitability has limits.
For now, Alibaba has the cash it wanted and two of its most senior leaders have skin in the game at post-dilution prices, with $15.3 million in insider purchases on August 24.
Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.

1 hour ago
20









English (US) ·